q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

September 2019 Medicare Drug List Updates: Thirty-four (34) Medications Added to 2019 Medicare Part D Drug Plan Formularies

Category: Monthly Formulary Changes
Published: Sep, 17 2019 01:09:56
< Previous
Next >

We now have the recently released September 2019 Medicare Part D prescription drug plan formulary (drug lists) data online and included in our Formulary Browser and Drug Finder.  The September formulary updates include the addition of 43 new National Drug Codes (NDCs), representing 34 different prescription drugs, many with multiple strengths.  The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).

Highlights of the September 2019 formulary updates include seven newly-added generic drugs:  The September Medicare Part D drug data includes twenty generic medications, with seven (7) being newly-introduced generic drugs.  These drugs include:

  • BESER [Cutivate®],
  • BOSENTAN [Tracleer®], and
  • CINACALCET [Sensipar®],
  • ERLOTINIB [Tarceva®],
  • INSULIN LISPRO [Humalog KwikPen®],
  • LOTEPREDNOL ETABONATE [Lotemax®], and
  • PENICILLAMINE [Cuprimine®].

You can see our article "September 2019 Drug List Updates: Twenty (20) new generic drugs added to many Medicare Part D plan formularies" found at https://Q1News.com/771.html for more about coverage for all of the new generics.

The September 2019 Formulary Update Includes Six Newly-Added Brand-Name Drugs:  The September drug data also updates includes the introduction of six (6) newly introduced brand-name drugs, some with multiple strengths. These drugs include:

  • DUOBRII®,
  • LEXETTE®,
  • MAYZENT®,
  • RHOFADE®,
  • VARIZIG®, and
  • VYNDAQEL®.
Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.

Reminders about Medicare prescription drug plan formulary changes

(1) Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.

(2) Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Reminder: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: Q1FAQ.com/155

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 43 new NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 2
New Drug 17
New Drug and Strength 14
New Manufacturer and Delivery Form 1
New Manufacturer and Strength 4
New Strength 5
Total New NDCs 43

The following chart details the 43 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Code (NDC) or Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state).  You can then change the state in our search form for details of drug coverage in your service area.


NDC Drug Name Number of
PDP Formularies*		 Number of
MAPD Formularies*		 Notes
49908011814ADAPALENE 0.1% SWAB MED. SWAB [Plixda]19New Manufacturer and Delivery Form
69097022316ALENDRONATE SODIUM 35 MG TABLET [Fosamax]62352New Manufacturer and Strength
00023588512ALORA 0.025 MG PATCH TDSW [Vivelle-Dot]548New Drug
00085173302AVELOX 400 MG TABLET27New Drug
43538097060BESER 0.05% LOTION [Cutivate]1273New Drug
68382044714BOSENTAN 125 MG TABLET [Tracleer]54286New Drug and Strength
68382044614BOSENTAN 62.5 MG TABLET [Tracleer]54286New Drug and Strength
23155062102CALCIUM ACETATE 667 MG TABLET [PhosLo]57304New Drug
13811071710CHLORZOXAZONE 375 MG TABLET [Lorzone]147New Drug and Strength
13811071810CHLORZOXAZONE 750 MG TABLET [Lorzone]147New Drug and Strength
00378619793CINACALCET HCL 30 MG TABLET [Sensipar]59335New Drug and Strength
00378619693CINACALCET HCL 60 MG TABLET [Sensipar]59335New Drug and Strength
00378619593CINACALCET HCL 90 MG TABLET [Sensipar]59335New Drug and Strength
00023615004CRINONE 4% GEL GEL/PF APP887New Strength
00187065301DUOBRII 0.01%-0.045% LOTION116New Drug
00254203380EMOQUETTE 28 DAY TABLET [Solia]60331New Drug
00378713293ERLOTINIB HCL 100 MG TABLET [Tarceva]62349New Drug and Strength
00378713393ERLOTINIB HCL 150 MG TABLET [Tarceva]62349New Drug and Strength
00378713193ERLOTINIB HCL 25 MG TABLET [Tarceva]62349New Drug and Strength
00023614601FIORINAL 50-325-40 MG CAPSULE08New Manufacturer and Strength
70370204806INGREZZA INITIATION PACK CAPSULE DS PK797New Delivery Form
66733082259INSULIN LISPRO 100 UNIT/ML INSULN PEN [Humalog KwikPen]1057New Drug and Strength
66733077301INSULIN LISPRO 100 UNIT/ML VIAL [Humalog KwikPen]1056New Drug and Strength
00023601260KADIAN ER 20 MG CAPSULE ER PEL05New Strength
00023601660KADIAN ER 60 MG CAPSULE ER PEL05New Strength
51167060001KALYDECO 25 MG GRANULES PACKET58336New Strength
51862060450LEXETTE 0.05% FOAM113New Drug
50383026510LOTEPREDNOL ETABONATE 0.5% EYE DROPPER [Lotemax]31277New Drug
00078097950MAYZENT 0.25 MG TABLET15130New Drug and Strength
00078098615MAYZENT 2 MG TABLET15130New Drug and Strength
42806005001MEPERIDINE 50 MG TABLET [Meperitab]443New Manufacturer and Strength
00093590786MESALAMINE DR 400 MG CAPSULE (DRTAB) [Delzicol]36251New Drug
10702010201METHYLPHENIDATE 20 MG TABLET [Ritalin]62352New Manufacturer and Strength
00713063437MOMETASONE FUROATE 0.1% CREAM (g) [Elocon]56347New Drug
00254203280ORSYTHIA-28 TABLET [Vienva]58329New Drug
43975030910PENICILLAMINE 250 MG CAPSULE [Cuprimine]13110New Drug
00023530030RHOFADE 1% CREAM (g)09New Drug
50458033001RISPERDAL 3 MG TABLET28New Strength
60432056160TRIAMCINOLONE 0.1% LOTION [Kenalog]57345New Drug
70257012611VARIZIG 125 UNIT/1.2 ML VIAL24144New Drug
62175048737VERAPAMIL ER PM 300 MG CAPSULE 24H PCT [Verelan PM]55338New Drug
00069197540VYNDAQEL 20 MG CAPSULE371New Drug
00078069484ZYKADIA 150 MG TABLET62335New Delivery Form
*The number of formularies counts the unique formularies that offer this medication. As a note, the same formulary can be used by one or many different Medicare Part D plans. The same formulary can be used by both PDP and MAPD plans.




Our online Formulary Browser and Drug Finder
You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.



Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.